Staphylococcus aureus immune globulin - Biotest

Drug Profile

Staphylococcus aureus immune globulin - Biotest

Alternative Names: S. aureus immune globulin - Biotest; Staphylococcus aureus Immune Globulin Intravenous (human) - Biotest; Altastaph

Latest Information Update: 31 May 2012

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Nabi Biopharmaceuticals
  • Developer Biotest Pharmaceuticals
  • Class Antibacterials; Immunoglobulins; Polyclonal antibodies
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    Yes - Staphylococcal infections

Highest Development Phases

  • Discontinued Staphylococcal infections

Most Recent Events

  • 31 May 2012 Discontinued - Phase-II for Staphylococcal infections in USA (IV)
  • 04 Dec 2007 Biotest Pharma acquires Nabi Biopharmaceuticals
  • 07 Jun 2007 Suspended - Phase-II for Staphylococcal infections in USA (IV)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top